On Tuesday, Alkermes plc (NASDAQ: ALKS) opened lower -2.27% from the last session, before settling in for the closing price of $31.31. Price fluctuations for ALKS have ranged from $22.90 to $32.88 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 10.61%. Company’s average yearly earnings per share was noted 82.21% at the time writing. With a float of $158.78 million, this company’s outstanding shares have now reached $161.78 million.
Let’s determine the extent of company efficiency that accounts for 2100 employees. In terms of profitability, gross margin is 82.31%, operating margin of 20.77%, and the pretax margin is 22.07%.
Alkermes plc (ALKS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Alkermes plc is 1.87%, while institutional ownership is 111.02%. The most recent insider transaction that took place on Dec 09 ’24, was worth 1,961,406. In this transaction EVP R&D, Chief Medical Officer of this company sold 61,151 shares at a rate of $32.07, taking the stock ownership to the 47,576 shares. Before that another transaction happened on Dec 09 ’24, when Company’s Director sold 2,691 for $31.85, making the entire transaction worth $85,708. This insider now owns 23,013 shares in total.
Alkermes plc (ALKS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 82.21% per share during the next fiscal year.
Alkermes plc (NASDAQ: ALKS) Trading Performance Indicators
Check out the current performance indicators for Alkermes plc (ALKS). In the past quarter, the stock posted a quick ratio of 3.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.29. Likewise, its price to free cash flow for the trailing twelve months is 15.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.96, a number that is poised to hit 0.75 in the next quarter and is forecasted to reach 1.78 in one year’s time.
Technical Analysis of Alkermes plc (ALKS)
Looking closely at Alkermes plc (NASDAQ: ALKS), its last 5-days average volume was 1.66 million, which is a drop from its year-to-date volume of 1.81 million. As of the previous 9 days, the stock’s Stochastic %D was 70.99%. Additionally, its Average True Range was 0.93.
During the past 100 days, Alkermes plc’s (ALKS) raw stochastic average was set at 78.78%, which indicates a significant increase from 66.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.55% in the past 14 days, which was lower than the 36.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.41, while its 200-day Moving Average is $26.64. However, in the short run, Alkermes plc’s stock first resistance to watch stands at $31.22. Second resistance stands at $31.85. The third major resistance level sits at $32.18. If the price goes on to break the first support level at $30.26, it is likely to go to the next support level at $29.93. Now, if the price goes above the second support level, the third support stands at $29.30.
Alkermes plc (NASDAQ: ALKS) Key Stats
There are currently 161,803K shares outstanding in the company with a market cap of 4.95 billion. Presently, the company’s annual sales total 1,663 M according to its annual income of 355,760 K. Last quarter, the company’s sales amounted to 378,140 K and its income totaled 92,380 K.
